Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
Public ClinicalTrials.gov record NCT00548249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose Ranging Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) Versus Control in Subjects With ESRD Receiving Chronic Hemodialysis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Dialysate containing soluble iron (Soluble Ferric Pyrophosphate) is safe and effective in maintaining physiological iron levels during chronic hemodialysis.
Study identification
- NCT ID
- NCT00548249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Jan 2010 (Actual)
- Last update posted
- Dec 2, 2020
2007 – 2010
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator | Tempe | Arizona | 85284 | — |
| Investigator | Hacienda Heights | California | 91745 | — |
| Investigator | Los Angeles | California | 90059 | — |
| Investigator | Whittier | California | 90603 | — |
| Investigative Site | Augusta | Georgia | 30901 | — |
| Investigator | Meridian | Idaho | 83642 | — |
| Investigator | Chicago | Illinois | 60617 | — |
| Investigative Site | Louisville | Kentucky | 40202-1718 | — |
| Investigator | New Orleans | Louisiana | 70115 | — |
| Investigator | Springfield | Massachusetts | 01107 | — |
| Investigative Site | Detroit | Michigan | 48202 | — |
| Investigator | Hackensack | New Jersey | 07601 | — |
| Investigator | Brooklyn | New York | 11212 | — |
| Investigator | Great Neck | New York | 11021 | — |
| Investigator | Mineola | New York | 11501 | — |
| Investigator | New York | New York | 10013 | — |
| Investigator | Ridgewood | New York | 11385 | — |
| Investigator | Winston-Salem | North Carolina | 27103 | — |
| Investigative Site | Canton | Ohio | 44718 | — |
| Investigator | Cincinnati | Ohio | 45229 | — |
| Investigative Site | Hershey | Pennsylvania | 17033 | — |
| Investigator | Arlington | Texas | 76011 | — |
| Investigator | Fort Worth | Texas | 76105 | — |
| Investigator | McAllen | Texas | 78503 | — |
| Investigator | San Antonio | Texas | 78207 | — |
| Investigator | Arlington | Virginia | 22206 | — |
| Investigator | Seattle | Washington | 92133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00548249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00548249 live on ClinicalTrials.gov.